We are live on
!
Find out more
CM
CM Management Portfolio holdings
AUM
$120M
1-Year Est. Return
37.12%
This Fund
S&P 500
This Quarter
Est. Return
+0.55%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$132M
AUM Growth
-$1.72M
(-1.3%)
Cap. Flow
+$4.78M
Cap. Flow
% of AUM
3.61%
Top 10 Holdings %
Top 10 Hldgs %
39.48%
Holding
103
New
13
Increased
34
Reduced
13
Closed
15
Top Buys
| 1 |
CADE
Cadence Bank
CADE
|
+$1.9M |
| 2 |
Energy Transfer Partners
ET
|
+$1.59M |
| 3 |
NEUE
NeueHealth
NEUE
|
+$1.59M |
| 4 |
Kyndryl
KD
|
+$1.08M |
| 5 |
Agnico Eagle Mines
AEM
|
+$1.06M |
Top Sells
| 1 |
CADE
Cadence Bancorporation
CADE
|
+$1.98M |
| 2 |
Travere Therapeutics
TVTX
|
+$1.94M |
| 3 |
BP
BP
|
+$1.64M |
| 4 |
ENLC
ENLINK MIDSTREAM, LLC
ENLC
|
+$1.36M |
| 5 |
B
Barrick Mining
B
|
+$1.14M |
Sector Composition
| 1 | Healthcare | 37.78% |
| 2 | Financials | 15.15% |
| 3 | Energy | 11.51% |
| 4 | Materials | 8.38% |
| 5 | Technology | 6.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Heron Therapeutics
HRTX
$89M
| $457K | 0.35% |
50,000
-10,000
| -17% | -$102K |
|
|
NBSE
77
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| $422K | 0.32% |
7,500
+3,750
| +100% | +$252K |
|
78
Femasys
FEMY
$9.06M
| $390K | 0.29% |
5,000
+2,000
| +67% | +$233K |
|
79
Nektar Therapeutics
NKTR
$2.3B
| $338K | 0.26% |
1,667
-1,666
| -50% | -$361K |
|
|
ICPT
80
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $326K | 0.25% |
20,000
-25,000
| -56% | -$421K |
|
81
Elicio Therapeutics
ELTX
$84M
| $324K | 0.24% |
11,178
+1,803
| +19% | +$91.2K |
|
82
Aterian
ATER
$14.3M
| $308K | 0.23% |
+6,250
| New | +$462K |
|
83
inTEST
INTT
$171M
| $254K | 0.19% |
20,000
-80,000
| -80% | -$1.04M |
|
84
Relmada Therapeutics
RLMD
$577M
| $225K | 0.17% |
+10,000
| New | +$222K |
|
|
SVC
85
Service Properties Trust
SVC
$1.1B
| $220K | 0.17% |
5,000
| – | – |
|
86
Newell Brands
NWL
$2.18B
| $218K | 0.16% |
+10,000
| New | +$226K |
|
|
BCEL
87
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $197K | 0.15% |
65,000
-15,000
| -19% | -$70.1K |
|
|
SPPI
88
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $191K | 0.14% |
150,000
-150,000
| -50% | -$268K |
|
89
authID Inc
AUID
$15.2M
| – | – |
-1,250
| Closed | -$112K |
|
|
90
BP
BP
$107B
| – | – |
-60,000
| Closed | -$1.64M |
|
91
EQT Corp
EQT
$31.1B
| – | – |
-50,000
| Closed | -$1.02M |
|
92
Hewlett Packard
HPE
$61.4B
| – | – |
-30,000
| Closed | -$428K |
|
|
PTPI
93
DELISTED
Petros Pharmaceuticals
PTPI
| – | – |
-400
| Closed | -$200K |
|
94
Saic
SAIC
$4.88B
| – | – |
-12,500
| Closed | -$1.07M |
|
|
95
Travere Therapeutics
TVTX
$5.31B
| – | – |
-80,000
| Closed | -$1.94M |
|
96
VYNE Therapeutics
VYNE
$25.2M
| – | – |
-7,986
| Closed | -$200K |
|
|
WBA
97
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
-20,000
| Closed | -$941K |
|
|
ENLC
98
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| – | – |
-200,000
| Closed | -$1.36M |
|
|
AVTA
99
DELISTED
Avantax, Inc. Common Stock
AVTA
| – | – |
-65,000
| Closed | -$1.01M |
|
|
CRTDW
100
DELISTED
Creatd Inc. Warrant
CRTDW
| – | – |
-103,400
| Closed | -$72K |
|
Similar funds
AA
CC
DG
ACM
WAG
YMRC
IW
BCWM
CM Management's Q4 2021 Portfolio in Review
As of Q4 2021, CM Management held 103 positions worth $132M, down 1.3% from $134M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
CM Management deployed $4.78M of net new capital in Q4 2021, opening 13 new positions and adding to 34 existing holdings. Its largest new stake was Cadence Bank: 63,000 shares worth $1.88M.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 38% a quarter earlier, followed by Financials and Energy.
On the sell side, the largest reduction was Barrick Mining, an estimated $1.14M trimmed.
- CM Management's largest Q4 2021 buy was Cadence Bank: 63,000 shares worth $1.88M.
- CM Management added most to NeueHealth in Q4 2021, an estimated $1.59M increase.
- CM Management's biggest Q4 2021 reduction was Barrick Mining, cutting an estimated $1.14M.
- CM Management fully exited Cadence Bancorporation in Q4 2021, selling an estimated $1.98M.
- CM Management's ten largest holdings make up 39% of its $132M portfolio in Q4 2021.
- CM Management opened 13 new positions and closed 15 in Q4 2021.
- CM Management's portfolio value fell 1.3% quarter-over-quarter to $132M.
Based on CM Management's 13F filing for Q4 2021, filed 2 Feb 2022.